Antiplatelet treatment in the primary prophylaxis of cardiovascular disease in patients with arterial hypertension

The benefits of using acetylsalicylic acid (ASA) in the primary prophylaxis of cardiovascular diseases may only slightly exceed the risk of serious bleeding. This warrants the search for alternative, safer preparations with antiaggregatory properties, which could be used in patients burdened with ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Osińska, Angelika, Osiński, Maciej, Krasińska, Aleksandra, Begier-Krasińska, Beata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2017
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519840/
https://www.ncbi.nlm.nih.gov/pubmed/28747946
http://dx.doi.org/10.5114/kitp.2017.68745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519840/
https://www.ncbi.nlm.nih.gov/pubmed/28747946
http://dx.doi.org/10.5114/kitp.2017.68745

Ejemplares similares